home / stock / trvn / trvn quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-01-22 | 2.15 | 2.21 | 2.22 | 2.12 | 2,683,993 |
2021-01-21 | 2.18 | 2.16 | 2.18 | 2.12 | 1,586,598 |
2021-01-20 | 2.19 | 2.15 | 2.2 | 2.12 | 2,196,207 |
2021-01-19 | 2.19 | 2.18 | 2.25 | 2.14 | 3,119,217 |
2021-01-18 | 2.19 | 2.12 | 2.24 | 2.11 | 3,661,033 |
2021-01-15 | 2.19 | 2.12 | 2.24 | 2.11 | 3,480,135 |
2021-01-14 | 2.22 | 2.18 | 2.24 | 2.16 | 2,372,629 |
2021-01-13 | 2.22 | 2.2301 | 2.2387 | 2.16 | 2,364,063 |
2021-01-12 | 2.21 | 2.21 | 2.24 | 2.15 | 2,864,215 |
2021-01-11 | 2.33 | 2.18 | 2.34 | 2.16 | 5,115,043 |
2021-01-08 | 2.42 | 2.4 | 2.47 | 2.38 | 2,991,652 |
2021-01-07 | 2.24 | 2.42 | 2.42 | 2.24 | 4,288,837 |
2021-01-06 | 2.1731 | 2.22 | 2.31 | 2.17 | 3,914,795 |
2021-01-05 | 2.09 | 2.16 | 2.18 | 2.065 | 2,261,318 |
2021-01-04 | 2.12 | 2.11 | 2.15 | 2.06 | 3,716,964 |
2021-01-01 | 2.15 | 2.14 | 2.175 | 2.08 | 3,545,270 |
2020-12-31 | 2.15 | 2.14 | 2.175 | 2.08 | 3,421,691 |
2020-12-30 | 2.13 | 2.14 | 2.2 | 2.09 | 2,056,702 |
2020-12-29 | 2.2 | 2.13 | 2.22 | 2.1 | 3,703,524 |
2020-12-28 | 2.29 | 2.2 | 2.33 | 2.2 | 3,473,908 |
News, Short Squeeze, Breakout and More Instantly...
CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate ...
-- Build-out of customer-facing team on track for this quarter OLINVYK comprehensive product dossier / health economic model now available to facilitate formulary reviews -- CHESTERBROOK, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a b...
-- P resentations highlight efficacy of TRV045 in animal models of neuropathic pain and epilepsy TRV045 selectively targets the S1P 1 receptor without associated lymphopenia IND filing on track for 1H 2021 -- CHESTERBROOK...